New study to measure psoriasis treatment success beyond the skin
NCT ID NCT07495657
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study will follow 45 adults with severe plaque psoriasis to see how standard treatment affects their skin, dermoscopic images, and quality of life. Participants will be evaluated at the start and again after 12 and 24 weeks of treatment. The goal is to better understand the full impact of therapy on both physical signs and daily well-being.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS VULGARIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an ancient herbal mix tame psoriasis flares?
- Small study to uncover how psoriasis drug tames the immune system
- Psoriasis drug trial aims to calm overactive immune cells
- Diabetes drug cream shows promise for psoriasis in new trial
- Blood test may end guesswork in psoriasis dosing
- Could a plant cream soothe psoriasis? new trial tests it